ImmunologybioRxivPreprint
An improved method to produce clinical scale natural killer cells from human pluripotent stem cells
This paper improves a method to produce clinical-scale natural killer cells from human pluripotent stem cells, enabling rapid, homogeneous production for immunotherapy.
DOI 10.1101/614792